Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients

Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients

Uzma Zaidi,1 Bushra Kaleem,2 Munira Borhany,1 Sidra Maqsood,2 Naveena Fatima,2 Gul Sufaida,3 Saqib Hussain Ansari,1 Tasneem Farzana,1 Tahir Sultan Shamsi1 1Department of Clinical Hematology, National Institute of Blood Diseases & Bone Marrow Transplantation, Karachi, Pakistan; 2Department of...

Full description

Bibliographic Details
Main Authors: Zaidi U, Kaleem B, Borhany M, Maqsood S, Fatima N, Sufaida G, Ansari SH, Farzana T, Shamsi TS
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:Cancer Management and Research
Subjects:
Chronic Myeloid Leukemia
Tyrosine Kinase Inhibitors
Nilotinib
Molecular response
Online Access:https://www.dovepress.com/early-and-sustained-deep-molecular-response-achieved-with-nilotinib-in-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/early-and-sustained-deep-molecular-response-achieved-with-nilotinib-in-peer-reviewed-article-CMAR

Similar Items